Thirty-Day Mortality and Complication Rates in Total Joint Arthroplasty After a Recent COVID-19 Diagnosis

• DOI: 10.2106/jbjs.22.01317
• Publication Date: 2023-06-24T19:01:29Z
• Authors: Jami D. Pincavitch; John J. Pisquiy; Sijin Wen; Nicole Bryan; Jeffrey Ammons; Priyal Makwana; Matthew J. Dietz
• Keywords: Joint arthroplasty; 2019-20 coronavirus outbreak

The risk of postoperative complications in patients who had a positive COVID-19 test prior to total joint arthroplasty (TJA) is unknown. purpose this investigation was study the and mortality associated with recent diagnosis TJA. Patients undergoing primary revision hip arthroplasties (THAs) or knee (TKAs) were identified using National COVID Cohort Collaborative (N3C) Data Enclave. divided into COVID-19-positive group (positive polymerase chain reaction [PCR] test, clinical diagnosis, antibody test) COVID-19-negative group, time from noted. There no differentiation between severity acuity illness available. reviewed included venous thromboembolism, pneumonia, acute myocardial infarction, readmission rates, 30-day rates. A 85,047 underwent elective TJA study, 3,516 (4.13%) diagnosis. diagnosed at 2 weeks increased pneumonia (odds ratio [OR], 2.46), infarction (OR, 2.90), sepsis within 90 days 2.63), 10.61). are greater including mortality. Our analysis presents critical data that should be considered recently COVID-19. Prognostic Level III . See Instructions for Authors complete description levels evidence.